ARCHIVES

NCI Anticipates 60% Decline In Number Of New Trials By Cooperative Groups.

This article is from The Cancer Letter archive.

Vol. 33 No. 01 | January 12, 2007

Download PDF Visit The Full Archive

Related Articles

Phase III Trebananib Trial Fails OS Endpoint In Recurrent Platinum-Resistant Ovarian Cancer

November 28, 2014

Connie Mack Joins Washington Office Of Shaw Pittman.

March 2, 2001

Congress Holds Recision Hearings

February 28, 1975

DCT Board Okays Extension Of Phase 1 Master Agreements, Increase To $4 Million

February 27, 1987

CCOP RFA Response So Far Points To More Consortia Applications, Reasonable Geographic Distribution

August 20, 1982

In Brief: Murphy Choice Of Ohio State Search Committee To Head Cancer Hospital; Decision Due In Oct.

September 19, 1986